Skip to content

Treatment adherence to nucleos(t)ide analogues in Chinese patients with hepatitis B virus related hepatocellular carcinoma: a single-center cross-sectional study

Treatment adherence to nucleos(t)ide analogues in Chinese patients with hepatitis B virus related hepatocellular carcinoma: a single-center cross-sectional study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037888
Enrollment
Unknown
Registered
2020-09-03
Start date
2020-08-12
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B virus related hepatocellular carcinoma

Interventions

Case series:Nil

Sponsors

The Third Affiliated Hospital of Naval Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with HBV related HCC were definitely diagnosed; 2. Patients with indications for antiviral therapy and taking at least one NUCs drug for CHB; 3. Patients with aged >=18 years old; 4. Patients who understand and agree with the purpose and method of the study.

Exclusion criteria

Exclusion criteria: 1. Patients with other types of hepatitis, such as hepatitis C or hepatitis D; 2. Patients with AIDS; 3. Patients with decompensated liver disease; 4. Patients who have not been told the truth of liver cancer; 5. Pregnant women; 6. Patients who need the help of others to take medicine or have cognitive impairment to a certain extent and can not understand the content of the questionnaire.

Design outcomes

Primary

MeasureTime frame
Medication compliance of patients;Medication compliance of patients;

Countries

China

Contacts

Public ContactChen Anni

The Third Affiliated Hospital of the Second Military Medical University

15902165325@163.com+86 15902165325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026